Michael Cherny
Stock Analyst at Leerink Partners
(4.10)
# 1,588
Out of 4,463 analysts
557
Total ratings
56.5%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Reiterated: Buy | $230 | $179.52 | +28.12% | 20 | Jun 30, 2026 | |
| CERT Certara | Reiterated: Buy | $13 → $8 | $6.92 | +15.61% | 16 | Jun 16, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Hold | n/a | $11.03 | - | 34 | Jun 12, 2026 | |
| MDLN Medline | Maintained: Buy | $56 → $52 | $41.81 | +24.37% | 4 | Jun 12, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Hold | $125 → $145 | $178.73 | -18.87% | 17 | May 28, 2026 | |
| DOCS Doximity | Rated: Buy | $79 → $25 | $21.90 | +14.16% | 14 | May 15, 2026 | |
| HIMS Hims & Hers Health | Maintained: Hold | n/a | $37.70 | - | 32 | Apr 16, 2026 | |
| CVS CVS Health | Reiterated: Buy | $98 | $104.42 | -6.15% | 66 | Mar 24, 2026 | |
| HSIC Henry Schein | Reiterated: Hold | $87 | $84.77 | +2.63% | 31 | Feb 24, 2026 | |
| NVST Envista Holdings | Upgraded: Buy | $35 | $27.32 | +28.11% | 24 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $21.36 | +101.31% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $187 → $240 | $238.47 | +0.64% | 38 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $232 → $256 | $204.91 | +24.93% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $215.91 | -2.74% | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $6 | $3.56 | +68.54% | 21 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 → $342 | $284.96 | +20.02% | 14 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $455 → $490 | $552.27 | -11.28% | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $349 → $361 | $287.03 | +25.77% | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $767.58 | - | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.09 | - | 23 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.78 | - | 35 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $9.01 | -16.76% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $498.44 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $138.45 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.22 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $5.10 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 | $0.3861 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $9.34 | n/a | 1 | Jan 5, 2022 |
Align Technology
Jun 30, 2026
Reiterated: Buy
Price Target: $230
Current: $179.52
Upside: +28.12%
Certara
Jun 16, 2026
Reiterated: Buy
Price Target: $13 → $8
Current: $6.92
Upside: +15.61%
DENTSPLY SIRONA
Jun 12, 2026
Maintained: Hold
Price Target: n/a
Current: $11.03
Upside: -
Medline
Jun 12, 2026
Maintained: Buy
Price Target: $56 → $52
Current: $41.81
Upside: +24.37%
ICON Public Limited Company
May 28, 2026
Maintained: Hold
Price Target: $125 → $145
Current: $178.73
Upside: -18.87%
Doximity
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $21.90
Upside: +14.16%
Hims & Hers Health
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $37.70
Upside: -
CVS Health
Mar 24, 2026
Reiterated: Buy
Price Target: $98
Current: $104.42
Upside: -6.15%
Henry Schein
Feb 24, 2026
Reiterated: Hold
Price Target: $87
Current: $84.77
Upside: +2.63%
Envista Holdings
Feb 6, 2026
Upgraded: Buy
Price Target: $35
Current: $27.32
Upside: +28.11%
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $21.36
Upside: +101.31%
Jan 13, 2026
Reiterated: Buy
Price Target: $187 → $240
Current: $238.47
Upside: +0.64%
Dec 14, 2025
Maintained: Buy
Price Target: $232 → $256
Current: $204.91
Upside: +24.93%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $215.91
Upside: -2.74%
Oct 9, 2025
Rated: Hold
Price Target: $5 → $6
Current: $3.56
Upside: +68.54%
Oct 8, 2025
Reiterated: Buy
Price Target: $323 → $342
Current: $284.96
Upside: +20.02%
Oct 8, 2025
Reiterated: Hold
Price Target: $455 → $490
Current: $552.27
Upside: -11.28%
Oct 6, 2025
Maintained: Buy
Price Target: $349 → $361
Current: $287.03
Upside: +25.77%
Oct 6, 2025
Maintained: Buy
Price Target: n/a
Current: $767.58
Upside: -
Oct 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.09
Upside: -
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $29.78
Upside: -
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $9.01
Upside: -16.76%
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $498.44
Upside: n/a
Sep 4, 2024
Maintained: Hold
Price Target: n/a
Current: $138.45
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.22
Upside: n/a
Jun 14, 2023
Maintained: Buy
Price Target: $22
Current: $5.10
Upside: n/a
May 11, 2023
Maintained: Sell
Price Target: $11
Current: $0.3861
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7.5
Current: $9.34
Upside: n/a